$ENOV News
Last published 6d ago
- 6d agoENOVEnovis 3rd Quarter 2026 Earnings Call - ENOVIS CORPEarnings Call TranscriptsGood morning and welcome to the ANOVUS Third Quarter 2026 Earnings Conference Call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key
- 6d agoENOVEnovis CORP - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 9.01
- 6d agoENOVENOVIS Announces Third Quarter 2026 ResultsGlobeNewswireThird-quarter sales growth of 2% on a reported basis, 5% organic Third-quarter Reconstructive sales growth of 6% on a reported and organic basis Raising full-year 2026 guidance for adjusted EBITDA and adjusted EPS
- 2w agoKIDSOMDAENOVMYO+1PRISM MarketView Highlights Five Innovative Public Companies Supporting Strength and Mobility for National Physical Therapy MonthGlobeNewswireOrthoPediatrics, Omada Health, Enovis, Myomo and FIGS span the full arc of physical therapy, from childhood care and prevention to recovery and the professionals who deliver it NEW YORK, Oct. 22, 2026 (GLOBE
- 1mo agoENOVEnovis to Host Third Quarter 2026 Results Conference Call on November 5thGlobeNewswireDallas, TX, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE:ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to
- 2mo agoENOVEnovis Call Regarding eCential Robotics - ENOVIS CORPEarnings Call TranscriptsHello everyone, thank you for joining us and welcome to the Anovus call regarding the binding offer to acquire Essential Robotics. After today's prepared remarks, we will host a question and answer session. If you would
- 2mo agoENOVeCential Robotics Announces Binding Offer from EnovisPR NewswireeCential Robotics, a leading developer of enabling technologies and surgical robotics, today announced that Enovis™ Corporation (NYSE: ENOV) has...
- 2mo agoENOVEnovis Invests in Innovation with Binding Offer to Acquire eCential Robotics, a Leading Developer of Enabling Technologies and Surgical RoboticsGlobeNewswireEnhances Enovis’ enabling technology ecosystem to include robotic automation capabilities, empowering surgeons with a broader, integrated set of precision tools in the operating room. Creates a robotics center of
- 2mo agoENOVEnovis to Participate in the 2026 Wells Fargo Healthcare ConferenceGlobeNewswireDallas, TX, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE:ENOV), an innovation-driven, medical technology growth company, today announced that it will participate in the 2026 Wells Fargo HealthCare
- 3mo agoENOVEnovis 2nd Quarter 2026 Earnings Call - ENOVIS CORPEarnings Call TranscriptsThis video tutorial shows how to install Kali Linux 2017.1 LXDE on VMware Workstation or VMware Workspace. Kali LXD is a very simple and easy-to-use software that can be installed on your computer. To install it, click o
- 3mo agoENOVEnovis Announces Second Quarter 2026 ResultsGlobeNewswireSecond-quarter sales growth of 3% on a reported basis, 5% organicSecond-quarter Reconstructive sales grew 8% on a reported basis, 6% organicReaffirmed full-year 2026 guidance for revenue, adjusted EBITDA, adjusted EPS,
- 3mo agoENOVEnovis to Host Second Quarter 2026 Results Conference Call on August 6thGlobeNewswireDallas, TX, July 17, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE:ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to
- 4mo agoENOVEnovis™ Companion Animal Health Launches CT-RevitL™, the Next-Generation Laser Therapy System for Veterinary CareGlobeNewswireCT-RevitL™ launches in the United States, built on a foundation of 150+ published studies on photobiomodulation (PBM) therapy Designed to deliver deeper, faster and more consistent therapeutic outcomes for animals
- 5mo agoENOVEnovis Launches Spinamic® Hybrid Scoliosis Brace, Combining Corrective Performance with Improved Wearability for Children and TeensGlobeNewswireSpinamic combines the curve-correction efficacy of rigid bracing with the comfort and mobility of dynamic braces, offering an optimal balance of therapy and patient wearabilityAvailable in 10 off-the-shelf sizes with an
- 6mo agoENOVEnovis 1st Quarter 2026 Earnings CallENOVIS CORPEarnings Call TranscriptsLadies and gentlemen, thank you for standing by. Hello, and welcome to InnoVis first quarter 2025 earnings call. All lines have been placed on mute to prevent any background noise. Thank you. I would like to turn the con
- 6mo agoENOVEnovis Announces First Quarter 2026 ResultsGlobeNewswireFirst-quarter sales growth of 5% on a reported basisFirst-quarter Reconstructive sales grew 11% on a reported basisReiterating full-year 2026 revenue, adjusted EBITDA, adjusted EPS, and Free Cash Flow Conversion guidance
- 6mo agoAPTXDBDENOVLH+4Knoa Pharma Begins Operations as a New, Public Health-Focused Company Dedicated to Supporting Patients and Abating the Opioid CrisisBusiness WireNew Foundation Trustees and Company Board Appointed to Oversee Knoa Pharma's Public Health Purpose; Company Board to Ensure Safe and Responsible Operations Knoa Pharma LLC ("Knoa Pharma") today begins operations as an
- 7mo agoENOVEnovis to Host First Quarter 2026 Results Conference Call on May 7thGlobeNewswireDallas, TX, April 10, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE:ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast
- 8mo agoENOVUpdate: Enovis Announces Fourth Quarter and Full Year 2025 ResultsGlobeNewswireContinued commercial momentum with full year 2025 sales growth of 7% on a reported basis and 6% organically Full year 2025 Reconstructive sales grew 10% Y/Y on a reported basis and 8% on an organic basis Full year
- 8mo agoENOVEnovis Announces Fourth Quarter and Full Year 2025 ResultsGlobeNewswireContinued commercial momentum with full year 2025 sales growth of 7% on a reported basis and 6% organically Full year 2025 Reconstructive sales grew 10% Y/Y on a reported basis and 8% on an organic basis Full year
- 9mo agoENOVEnovis to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceGlobeNewswireDallas TX, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE:ENOV), an innovation-driven, medical technology growth company, today announced that management will participate in the BTIG 13th Annual
- 9mo agoENOVEnovis to Host Fourth Quarter and Full Year 2025 Results Conference Call on February 26thGlobeNewswireDallas, TX, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE:ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast
- 10mo agoENOVEnovis to Participate in the 44th Annual J.P. Morgan Healthcare ConferenceGlobeNewswireDallas, TX, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE:ENOV), an innovation-driven, medical technology growth company, today announced that its management team will meet with investors at the
- 10mo agoENOVEnovis Appoints Oliver Engert as Chief Administrative OfficerGlobeNewswireDallas, TX, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE:ENOV), an innovation-driven medical technology company, has announced that Oliver Engert has been appointed Chief Administrative Officer,
- 1y agoENOVEnovis Announces Third Quarter 2025 ResultsGlobeNewswireDiversified growth platform delivers third-quarter sales growth of 9% on a reported basis, 7% organically Third-quarter Reconstructive sales grew 12% year-over-year on a reported basis, 9% organically October
- 1y agoENOVEnovis announces webcast and conference call for Third Quarter 2025 Results and participation in upcoming investor conferencesGlobeNewswireDallas, TX, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation ("Enovis" or "the Company") (NYSE:ENOV), an innovation-driven medical technology growth company, announced today it will host an investor
- 1y agoENOVEnovis completes sale of its Dr. Comfort Footcare Solutions business for proceeds of up to $60 millionGlobeNewswireWilmington, DE, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation ("Enovis" or "the Company") (NYSE:ENOV), an innovation-driven medical technology growth company, today announced the sale of its Dr. Comfort
- 1y agoENOVEnovis Corporation Announces Time Change for Presentation at Baird 2025 Global Healthcare ConferenceGlobeNewswireWilmington, DE, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE:ENOV), an innovation-driven, medical technology growth company, today announced that it will now present at the Baird 2025 Global
- 1y agoENOVEnovis to Participate in Upcoming Investor ConferencesGlobeNewswireWilmington, DE, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE:ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate in the
- 1y agoENOVEnovis Corporation (ENOV) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoENOVEnovis Announces Second Quarter 2025 ResultsGlobeNewswireContinued commercial momentum with second-quarter sales growth of 7% on a reported basisSecond-quarter Reconstructive sales grew 11% year-over-year on a reported basis Wilmington, DE, Aug. 07, 2025 (GLOBE NEWSWIRE)
- 1y agoENOVEnovis to Participate in Upcoming Investor ConferencesGlobeNewswireWilmington, DE, June 06, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE:ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate in the
- 1y agoENOVEnovis Announces First Quarter 2025 ResultsGlobeNewswireContinued commercial momentum with first-quarter sales growth of 8% on a reported basis and strong adjusted EBITDA margin expansion First-quarter Reconstructive sales grew 11% year-over-year on a reported basis
- 1y agoENOVEnovis to Host First Quarter 2025 Results Conference Call on May 8thGlobeNewswireWilimington, DE, April 17, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE:ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live
- 1y agoENOVEnovis Announces Appointment of Damien McDonald as Chief Executive OfficerGlobeNewswireDamien McDonald appointed CEO, effective as of May 12, 2025Company reiterates guidance for first quarter revenues and aEBITDA WIlmington. DE, April 02, 2025 (GLOBE NEWSWIRE) -- Enovis�� Corporation ("Enovis" or
- 1y agoENOVEnovis™ to Exhibit Extensive Range of Foot & Ankle Solutions at ACFAS 2025GlobeNewswireWILMINGTON, DE, March 25, 2025 (GLOBE NEWSWIRE) -- Enovis™ (NYSE:ENOV), a global medical technology innovator, will feature its expanding portfolio of foot and ankle solutions at this year's American College of
- 1y agoENOVEnovis to Participate in Upcoming Investor ConferencesGlobeNewswireWilmington, DE, March 05, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE:ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate in the
- 1y agoENOVEnovis Announces Fourth Quarter and Full Year 2024 ResultsGlobeNewswireContinued commercial momentum with fourth-quarter sales growth of 23% on a reported basis and strong adjusted EBITDA margin expansion Fourth-quarter Reconstructive sales grew 59% year-over-year on a reported basis and
- 1y agoENOVEnovis Announces Planned CEO Succession ProcessGlobeNewswireWilmington, DE, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation ("Enovis" or "the Company") (NYSE:ENOV), a leader in medical technology innovation, announced today that Matt Trerotola has informed the
- 1y agoENOVEnovis to Host Fourth Quarter and Full Year 2024 Results Conference Call on February 26thGlobeNewswireWilmington, DE, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE:ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live
- 1y agoENOVEnovis™ Announces Leadership Change to International Surgical BusinessGlobeNewswireWilmington, DE, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Enovis™, a global medical technology innovator headquartered in the United States, announced recently that Davide Visentin will succeed Dr. Benjamin Reinmann as
- 1y agoENOVARCHCEIXSPGIMaplebear Set to Join S&P MidCap 400; Enovis to Join S&P SmallCap 600PR NewswireMaplebear Inc. (NASD: CART) will replace Enovis Corp. (NYSE: ENOV) in the S&P MidCap 400, and Enovis will replace Arch Resources Inc. (NYSE: ARCH) in ...
- 1y agoENOVEnovis to Participate in the 43rd Annual J.P. Morgan Healthcare ConferenceGlobeNewswireWilmington, DE, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE:ENOV), an innovation-driven, medical technology growth company, today announced that its management team will meet with investors at
- 1y agoENOVEnovis to Participate in Upcoming Investor ConferencesGlobeNewswireWilmington, DE, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE:ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate in the
- 2y agoENOVEnovis Corporation (ENOV) Q3 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoENOVEnovis Announces Third Quarter 2024 ResultsGlobeNewswireContinued commercial momentum with third-quarter sales growth of 21% on a reported basis and strong adjusted EBITDA margin expansionReconstructive sales grew 57% Y/Y on a reported basis and 9% on a Comparable
- 2y agoENOVEnovis to Host Third Quarter 2024 Results Conference Call on November 6thGlobeNewswireWilmington, DE, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE:ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live
- 2y agoENOVEnovis Appoints Tim Czartoski as President, U.S. Surgical and Global Product and Enabling TechnologiesGlobeNewswireWILMINGTON, DE, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Enovis™ (NYSE:ENOV), an innovation-driven medical technology growth company, is pleased to announce the appointment of Tim Czartoski to the position of
- 2y agoENOVEnovis™ Introduces the Next Generation of Foot and Ankle Surgery Offerings at AOFAS Annual MeetingGlobeNewswireWilmington, DE, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Enovis™ (NYSE:ENOV), an innovation-driven medical technology company, announced today it will unveil its new Tarsoplasty Percutaneous Lapidus System and offer
- 2y agoENOVEnovis Continues to Redefine Revision Knee Surgery with the Addition of EMPOWR™ Cones to EMPOWR Revision Knee™, Creating a Comprehensive Portfolio for Efficient Revision ProceduresGlobeNewswireWILMINGTON, DE, Aug. 20, 2024 (GLOBE NEWSWIRE) -- Enovis™ (NYSE:ENOV), an innovation-driven medical technology growth company, announced today the expansion of its EMPOWR Revision Knee™ system to include